The <scp>BACE</scp> ‐1 inhibitor <scp>CNP</scp> 520 for prevention trials in Alzheimer's disease

Ulf Neumann, Mike Ufer, Laura H. Jacobson, +29

EMBO Molecular Medicine

NMR Reporter Screening for the Detection of High-Affinity Ligands

Wolfgang Jahnke, Philipp Floersheim, Christian Ostermeier, +4

Angewandte Chemie International Edition

Chemical BiologyGray SkeletonBiochemistryNatural SciencesMedicine +12

β2/β3-di- and α/β3-tetrapeptide derivatives as potent agonists at somatostatin sst4 receptors

Caroline Nunn, Magnus Rueping, Daniel Langenegger, +6

Naunyn-Schmiedeberg s Archives of Pharmacology

Somatostatin Sst4 ReceptorsMedicineImmunologyPotent AgonistsNeuropeptide Receptor +6

SRA880, in vitro characterization of the first non-peptide somatostatin sst1 receptor antagonist

Daniël Hoyer, Caroline Nunn, Jason Hannon, +9

Neuroscience Letters

Vitro CharacterizationSignal TransductionMedicineImmunologyReceptor (Biochemistry) +6

<scp>AQW</scp>051, a novel, potent and selective<scp>α</scp>7 nicotinic<scp>ACh</scp>receptor partial agonist: pharmacological characterization and phase<scp>I</scp>evaluation

Dominik Feuerbach, Nicole Pezous, Kasra Shakeri‐Nejad, +11

British Journal of Pharmacology

Gamma-lactams—A novel scaffold for highly potent and selective α7 nicotinic acetylcholine receptor agonists

Albert Enz, Dominik Feuerbach, Mathias Frederiksen, +5

Bioorganic & Medicinal Chemistry Letters

Molecular PharmacologyBiochemistryMedicineNatural SciencesNicotine +6

Discovery of Umibecestat (CNP520): A Potent, Selective, and Efficacious β-Secretase (BACE1) Inhibitor for the Prevention of Alzheimer’s Disease

Rainer Machauer, Rainer Lueoend, Konstanze Hurth, +9

Journal of Medicinal Chemistry

Agonist properties of putative small-molecule somatostatin sst2 receptor-selective antagonists

Caroline Nunn, Daniel Langenegger, Konstanze Hurth, +3

European Journal of Pharmacology

Molecular PharmacologyAgonist PropertiesFunctional SelectivityMedicineReceptor (Biochemistry) +5

Discovery of a selective and biologically active low-molecular weight antagonist of human interleukin-1β

Ulrich Hommel, Konstanze Hurth, Jean‐Michel Rondeau, +21

Nature Communications

Decahydroisoquinoline derivatives as novel non-peptidic, potent and subtype-selective somatostatin sst3 receptor antagonists

Thomas Troxler, Konstanze Hurth, Karl-Heinrich Schuh, +4

Bioorganic & Medicinal Chemistry Letters

BiochemistryFunctional SelectivityMedicineDecahydroisoquinoline DerivativesMechanism Of Action +5